Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» magrolimab
magrolimab
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials
Reuters
Thu, 02/15/24 - 07:14 pm
Gilead Sciences
magrolimab
solid tumors
FDA puts hold on Gilead's blood cancer therapy trials
Reuters
Wed, 02/7/24 - 09:20 pm
Gilead Sciences
FDA
clinical trials
magrolimab
blood cancer
Gilead Axes Phase III Magrolimab Trial Based on Disappointing Data
BioSpace
Wed, 09/27/23 - 11:12 pm
Gilead Sciences
magrolimab
clinical trials
blood cancers
Gilead's magrolimab once again placed on partial clinical hold, another setback for Forty Seven bet
Fierce Biotech
Mon, 08/21/23 - 10:06 am
Gilead Sciences
MDS
magrolimab
clinical trials
AML
Gilead drug acquired in $5B buyout fails key blood cancer trial
BioPharma Dive
Mon, 07/24/23 - 11:47 am
Gilead Sciences
M&A
oncology
clinical trials
magrolimab
MDS
Forty Seven
Gilead’s CD47 trials freed of FDA hold—for the most part
Fierce Biotech
Mon, 04/11/22 - 07:23 pm
Gilead Sciences
clinical trials
CD47
magrolimab
acute myeloid leukemia
FDA
Gilead's CD47 clinical hold expands as CEO O'Day expresses 'sense of urgency' in getting trials back on track
Fierce Biotech
Wed, 02/2/22 - 12:15 pm
Gilead Sciences
clinical trials
clinical hold
magrolimab
AML
MDS
Gilead's $4.9B oncology bet hit with partial clinical hold, forcing pause of pivotal trials and raising doubts about CD47
Fierce Biotech
Wed, 01/26/22 - 11:12 am
Gilead Sciences
magrolimab
anti-CD47
FDA
clinical trials
oncology
clinical hold
Gilead taps brakes on $4.9B bet after rival's failure, pushing blood cancer data out to 2022
Fierce Biotech
Fri, 10/29/21 - 10:35 am
Gilead Sciences
Forty Seven
magrolimab
MDS
Gilead gets FDA breakthrough therapy status for magrolimab in MDS
Pharmaceutical Business Review
Wed, 09/16/20 - 10:37 am
Gilead Sciences
FDA
MDS
magrolimab
breakthrough therapy
Gilead trumpets data with newly-bought magrolimab in blood cancers
Pharmaforum
Sun, 05/31/20 - 11:53 pm
Gilead Sciences
ASCO 2020
Forty Seven
magrolimab
M&A
MDS
Gilead’s newly bought immunotherapy drug scores at ASCO
MedCity News
Fri, 05/29/20 - 12:30 pm
Gilead Sciences
ASCO 2020
magrolimab
clinical trials
AML
MDS
For Gilead, Its Coronavirus Treatment Is Icing on the Cake
Motley Fool
Fri, 03/27/20 - 10:56 am
Gilead Sciences
remdesivir
COVID-19
KTE-X19
magrolimab
This Cancer Drug Is Driving Forty Seven's Stock Higher
Motley Fool
Mon, 01/27/20 - 10:56 pm
Forty Seven
magrolimab
clinical trials
myelodysplastic syndrome
Forty Seven bucks the trend
EP Vantage
Thu, 01/23/20 - 12:02 pm
Forty Seven
CD47
hematology
magrolimab
colorectal cancer
This Small-Cap Biotech Rose as Much as 98.3% Today
Motley Fool
Mon, 12/9/19 - 11:30 pm
Forty Seven
ASH2019
magrolimab
monoclonal antibodies
AML